Peripheral metabolic alterations associated with pathological manifestations of Parkinson's disease in gut-brain axis-based mouse model
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Huh, Eugene | - |
dc.contributor.author | Choi, Jin Gyu | - |
dc.contributor.author | Lee, Mee Youn | - |
dc.contributor.author | Kim, Jin Hee | - |
dc.contributor.author | Choi, Yujin | - |
dc.contributor.author | Ju, In Gyoung | - |
dc.contributor.author | Eo, Hyeyoon | - |
dc.contributor.author | Park, Myoung Gyu | - |
dc.contributor.author | Kim, Dong-Hyun | - |
dc.contributor.author | Park, Hi-Joon | - |
dc.contributor.author | Lee, Choong Hwan | - |
dc.contributor.author | Oh, Myung Sook | - |
dc.date.accessioned | 2023-09-05T08:41:11Z | - |
dc.date.available | 2023-09-05T08:41:11Z | - |
dc.date.created | 2023-09-05 | - |
dc.date.issued | 2023-08 | - |
dc.identifier.issn | 1662-5099 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/gachon/handle/2020.sw.gachon/89070 | - |
dc.description.abstract | Introduction: Parkinson's disease (PD) is a representative neurodegenerative disease, and its diagnosis relies on the evaluation of clinical manifestations or brain neuroimaging in the absence of a crucial noninvasive biomarker. Here, we used non-targeted metabolomics profiling to identify metabolic alterations in the colon and plasma samples of Proteus mirabilis (P. mirabilis)-treated mice, which is a possible animal model for investigating the microbiota-gut-brain axis.Methods: We performed gas chromatography-mass spectrometry to analyze the samples and detected metabolites that could reflect P. mirabilis-induced disease progression and pathology.Results and discussion: Pattern, correlation and pathway enrichment analyses showed significant alterations in sugar metabolism such as galactose metabolism and fructose and mannose metabolism, which are closely associated with energy metabolism and lipid metabolism. This study indicates possible metabolic factors for P. mirabilis-induced pathological progression and provides evidence of metabolic alterations associated with P. mirabilis-mediated pathology of brain neurodegeneration. | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | FRONTIERS MEDIA SA | - |
dc.relation.isPartOf | FRONTIERS IN MOLECULAR NEUROSCIENCE | - |
dc.title | Peripheral metabolic alterations associated with pathological manifestations of Parkinson's disease in gut-brain axis-based mouse model | - |
dc.type | Article | - |
dc.type.rims | ART | - |
dc.description.journalClass | 1 | - |
dc.identifier.wosid | 001053362500001 | - |
dc.identifier.doi | 10.3389/fnmol.2023.1201073 | - |
dc.identifier.bibliographicCitation | FRONTIERS IN MOLECULAR NEUROSCIENCE, v.16 | - |
dc.description.isOpenAccess | Y | - |
dc.identifier.scopusid | 2-s2.0-85168656785 | - |
dc.citation.title | FRONTIERS IN MOLECULAR NEUROSCIENCE | - |
dc.citation.volume | 16 | - |
dc.contributor.affiliatedAuthor | Huh, Eugene | - |
dc.type.docType | Article | - |
dc.subject.keywordAuthor | Parkinson&apos | - |
dc.subject.keywordAuthor | s disease | - |
dc.subject.keywordAuthor | microbiota-gut-brain axis | - |
dc.subject.keywordAuthor | endogenous metabolites | - |
dc.subject.keywordAuthor | Proteus mirabilis | - |
dc.subject.keywordAuthor | glycation | - |
dc.subject.keywordPlus | PROTEUS-MIRABILIS | - |
dc.subject.keywordPlus | INFLAMMATION | - |
dc.subject.keywordPlus | DYSBIOSIS | - |
dc.subject.keywordPlus | GLUCOSE | - |
dc.relation.journalResearchArea | Neurosciences & Neurology | - |
dc.relation.journalWebOfScienceCategory | Neurosciences | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
1342, Seongnam-daero, Sujeong-gu, Seongnam-si, Gyeonggi-do, Republic of Korea(13120)031-750-5114
COPYRIGHT 2020 Gachon University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.